Cargando…

The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy

Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is...

Descripción completa

Detalles Bibliográficos
Autores principales: Dăscălescu, Dana, Corbu, Cătălina, Șram, Livia, Coviltir, Valeria, Constantin, Mihaela, Burcel, Miruna, Marinescu, Maria, Comber, Andrei, Potop, Vasile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Romanian Society of Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773116/
https://www.ncbi.nlm.nih.gov/pubmed/36589336
http://dx.doi.org/10.22336/rjo.2022.62
_version_ 1784855128932614144
author Dăscălescu, Dana
Corbu, Cătălina
Șram, Livia
Coviltir, Valeria
Constantin, Mihaela
Burcel, Miruna
Marinescu, Maria
Comber, Andrei
Potop, Vasile
author_facet Dăscălescu, Dana
Corbu, Cătălina
Șram, Livia
Coviltir, Valeria
Constantin, Mihaela
Burcel, Miruna
Marinescu, Maria
Comber, Andrei
Potop, Vasile
author_sort Dăscălescu, Dana
collection PubMed
description Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is usually connected to the systemic status of the patient. We presented the case of a 53-year-old female patient who complained of visual acuity loss in her right eye, associated with inferior visual field (VF) damage. Patient history revealed migraine attacks, raised arterial blood pressure (BP), mitral valve insufficiency and dyslipidemia. Systemic treatment included Sumatriptan for migraine attacks and Bisoprolol for arterial hypertension. Results: A complete ophthalmologic examination was performed, including a visual field examination and optic coherence tomography. Interdisciplinary consults, along with inflammatory biomarkers, brain scan and cardiovascular Doppler echography were used to establish the final diagnosis. Considering the patient’s history, systemic medication, clinical picture, paraclinical findings and interdisciplinary check-ups, NAAION was established as a diagnosis. Discussion: NAAION occurs more frequently after the age of 50 years old and may be associated with systemic factors such as nocturnal hypotension, diabetes, atherosclerosis, sleep apnea. In the present case, the association of medically induced nocturnal hypotension and vasoconstriction led to optic nerve ischemia. Conclusions: In a patient with multiple pathology, we must consider the systemic therapy when performing any clinical examination. Abbreviations: AAION = arteritic anterior ischemic optic neuropathy, AION = anterior ischemic optic neuropathy, BCVA = best corrected visual acuity, BP = blood pressure, CS = corticosteroid, IOP = intraocular pressure, LE = left eye, MRI = magnetic resonance imaging, NAAION = non-arteritic anterior ischemic optic neuropathy, OCT = optical coherence tomography, ON = optic nerve, OU = both eyes, RE = right eye
format Online
Article
Text
id pubmed-9773116
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Romanian Society of Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-97731162022-12-30 The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy Dăscălescu, Dana Corbu, Cătălina Șram, Livia Coviltir, Valeria Constantin, Mihaela Burcel, Miruna Marinescu, Maria Comber, Andrei Potop, Vasile Rom J Ophthalmol Case Reports Objective: To report a case of a non-arteritic anterior ischemic optic neuropathy (NAAION) in a patient treated with Sumatriptan. Materials and methods: NAAION represents a severe affection that frequently determines irreversible visual acuity damage. The exact cause is yet to be identified, but is usually connected to the systemic status of the patient. We presented the case of a 53-year-old female patient who complained of visual acuity loss in her right eye, associated with inferior visual field (VF) damage. Patient history revealed migraine attacks, raised arterial blood pressure (BP), mitral valve insufficiency and dyslipidemia. Systemic treatment included Sumatriptan for migraine attacks and Bisoprolol for arterial hypertension. Results: A complete ophthalmologic examination was performed, including a visual field examination and optic coherence tomography. Interdisciplinary consults, along with inflammatory biomarkers, brain scan and cardiovascular Doppler echography were used to establish the final diagnosis. Considering the patient’s history, systemic medication, clinical picture, paraclinical findings and interdisciplinary check-ups, NAAION was established as a diagnosis. Discussion: NAAION occurs more frequently after the age of 50 years old and may be associated with systemic factors such as nocturnal hypotension, diabetes, atherosclerosis, sleep apnea. In the present case, the association of medically induced nocturnal hypotension and vasoconstriction led to optic nerve ischemia. Conclusions: In a patient with multiple pathology, we must consider the systemic therapy when performing any clinical examination. Abbreviations: AAION = arteritic anterior ischemic optic neuropathy, AION = anterior ischemic optic neuropathy, BCVA = best corrected visual acuity, BP = blood pressure, CS = corticosteroid, IOP = intraocular pressure, LE = left eye, MRI = magnetic resonance imaging, NAAION = non-arteritic anterior ischemic optic neuropathy, OCT = optical coherence tomography, ON = optic nerve, OU = both eyes, RE = right eye Romanian Society of Ophthalmology 2022 /pmc/articles/PMC9773116/ /pubmed/36589336 http://dx.doi.org/10.22336/rjo.2022.62 Text en #x00A9; The Authors.Romanian Society of Ophthalmology https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Dăscălescu, Dana
Corbu, Cătălina
Șram, Livia
Coviltir, Valeria
Constantin, Mihaela
Burcel, Miruna
Marinescu, Maria
Comber, Andrei
Potop, Vasile
The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title_full The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title_fullStr The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title_full_unstemmed The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title_short The pathophysiology of Sumatriptan induced non-arteritic anterior ischemic optic neuropathy
title_sort pathophysiology of sumatriptan induced non-arteritic anterior ischemic optic neuropathy
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773116/
https://www.ncbi.nlm.nih.gov/pubmed/36589336
http://dx.doi.org/10.22336/rjo.2022.62
work_keys_str_mv AT dascalescudana thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT corbucatalina thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT sramlivia thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT coviltirvaleria thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT constantinmihaela thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT burcelmiruna thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT marinescumaria thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT comberandrei thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT potopvasile thepathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT dascalescudana pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT corbucatalina pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT sramlivia pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT coviltirvaleria pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT constantinmihaela pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT burcelmiruna pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT marinescumaria pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT comberandrei pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy
AT potopvasile pathophysiologyofsumatriptaninducednonarteriticanteriorischemicopticneuropathy